Patent · US Active

Composition comprising inhibitors of IRS-1 and of VEGF

US9682144B2 · kind B2 · utility

4Cited by
10References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2012
Grant dateJun 20, 2017
Priority date
Expiry dateJun 29, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a composition or kit of parts comprising an inhibitor of IRS-1 and an inhibitor of the VEGF pathway and to the use thereof for treating an angiogenic disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.